Tuesday – 19th November 2024– Conference Day 1 - ET (Eastern Time, GMT-05:00)
Tuesday – 19th November 2024– Conference Day 1 - ET (Eastern Time, GMT-05:00)
• Technology and tools o AI development and its influence on finance and accounting teams
• Hiring and talent development o Ensuring your organization for success with the right talent and training
• Bridging the gap between new technology implementation and success within teams
CPE Credits Available: 1.2
- Funso Olufade, PhD, MBA - Sr. Director – Head, Commercial Finance, Ascendis Pharma
- Nancy Bell - Vice President, Head of US Patient Value & Access, Takeda Oncology
• Splitting ownership of GTN
• Roles and responsibilities around GTN
• Allocating resources to GTN improvement
• Cross-functional collaboration
CPE Credits Available: 1.5
- Bal Ram - VP Finance, US Operations, Indivior
- Prakash Chainani - Vice President – Finance, HR & IT, Lifestar Pharma LLC (a Mankind Group Company)
- Amy Ramazio - Contract Forecasting & Analytics Director, GSK US Market Access
- Eckart Beuttenmueller - Director, Gross-to-Net Execution, Bayer Healthcare Pharmaceuticals, Inc.
- Dan Sacchetta - Director Managed Markets Finance- Gross-to-Net, Novartis
• How to utilize technology to capture real-time forecast vs actuals
• The framework to maintain GTN data and buildout of a commercial warehouse
• Stakeholders' discussion around forecasting
CPE Credits Available: 0.9
- Neel Shah - Director, RSM US
- Angelina Pigna - Senior Director, Commercial Accounting, Mirati Therapeutics
- Rohit Gupta - Director, Global Revenue Finance, Seagen
• Key organizational factors
• Working from Gross to Net
• Leveraging systems to support the process
CPE Credits Available: 0.9
- Timothy Bonn - Senior Director, Gross to Net, Breakaway Technologies
- Brett Nussbaum - Director of Gross to Net Accounting, Novartis
o Understanding the complexities of system integration
o Working through effective change management procedures
o Ways to improve GTN model
o Balancing the use of manual processes and automation
o Minimize volatility and true-up adjustments
CPE Credits Available: 1.4
- Tom Evegan - Principal, Life Sciences Consulting Leader, RSM US LLP
- Jeffrey Miller - Assistant Vice President and Corporate Controller, Lannett Company
- Chris Boneham - Vice President, Market Access US, Y-mAbs Therapeutics, Inc
- Ranish Singhvi - Vice President, Finance, Accord Healthcare
- Melissa Norton - Assistant Controller, Revenue, Tolmar
o Top 10 launch considerations
o Gradual product launch additions and considerations for manageability o Managing scalability within your company and department
o Post-launch expectations and looking to year’s ahead
o Operational best practices
o Pain points and challenges
CPE Credits Available: 1.4
- Jennifer Sharpe - Vice President, Gross-to-Net Consulting and Facilitator, Revenue Analytics Collaborative, IntegriChain